Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 18, 2018PLoS PathogensOpen Access

Pathogen-based precision medicine for drug-resistant tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMatthias I. GröschelAWA Sarah WalkerTWTjip S. van der Werf

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gröschel et al. (2018) studied this question.

synapsesocial.com/papers/6a79bbbbfbd9051d3b0dec9ehttps://doi.org/10.1371/journal.ppat.1007297
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment Outcomes in Multidrug-Resistant Tuberculosis2016 · 83 citations
  2. 2GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis2008 · 345 citations
  3. 3Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis2018 · 274 citations
  4. 4Specific<i>gyrA</i>gene mutations predict poor treatment outcome in MDR-TB2015 · 96 citations
  5. 5Major <i>Mycobacterium tuberculosis</i> Lineages Associate with Patient Country of Origin2009 · 185 citations